期刊文献+

支持HCV 1b亚基因组复制的细胞模型的建立 被引量:1

Establishment of a cell model supporting HCV 1b subgenomic replication
下载PDF
导出
摘要 目的建立一个稳定支持中国人群HCV1b亚基因组高效复制的体外细胞模型。方法构建中国人群HCV1b亚型亚基因组复制子质粒,通过体外转录的方法获得亚基因组复制子RNA,采用电穿孔技术把RNA转染到Huh-7.5.1细胞中,经过G418筛选含有HCV1b亚基因组的细胞集落。RT-PCR检测细胞集落中的HCV亚基因组以及Western blot检测细胞集落中的HCV蛋白的表达。用干扰素(IFN)处理含有HCV亚基因组的细胞,观察细胞中HCV RNA的变化。结果G418药物筛选得到了支持HCV1b亚基因组复制的细胞集落。RT-PCR检测有HCVR NANS4B的表达,Western blot检测有HCV的非结构蛋白NS5B的表达。IFN处理含有HCV复制子的细胞,HCV RNA水平明显降低。结论成功建立了支持中国人群HCV1b亚基因组高效复制的体外细胞模型,为进一步研究HCV致病机制、治疗药物筛选及疫苗方面的研究打下了基础。 Objective To establish a cell model for supporting HCV lb subgenomic replicon from Chinese population. Methods Plasmid containing HCV 1 b subgenomic replicon was constructed. HCV snbgenomic replicon RNA was obtained by transcription and then delivered into Huh-7.5. 1 cell by electroporation. After screening the cells in the medium containing G418, we detected the HCV RNA in the obtained cell colonies by RT-PCR and the HCV NSSB protein by western blot. The cell colonies which contain HCV RNA were treated by IFN in order to observe the diminished level of HCV RNA. Results In a period of 4 - 6 weeks after transfection, visible colonies were stained by crystal violet. The HCV subgenomic replicon RNA NS4B was detected by RT-PCR and the HCV NS5B protein was detected by western blot. After treatment by IFN, HCV RNA diminished obviously. Conclusion We have successfully established a cell model for supporting HCV 1 b subgenomic replicon of Chinese population replication in vitro. This cell model is a useful tool for the study on HCV pathogenesis, the screening of antiviral drugs and the development of vaccines.
出处 《基础医学与临床》 CSCD 北大核心 2009年第6期570-574,共5页 Basic and Clinical Medicine
基金 国家"863"计划(2006AA020504)
关键词 HCV 亚基因组复制子 电穿孔 HCV subgenomic replicon electroporation
  • 相关文献

参考文献12

  • 1霍艳英,徐德忠,赵小宁,李如琳,刘蓬勃,王全楚,王歆.西安和郑州地区丙型肝炎患者的HCV基因分型[J].第四军医大学学报,2002,23(8):749-751. 被引量:84
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro[J]. Proc Natl Acad Sci USA, 2005, 102 (26) : 9294 - 9299.
  • 4Rosen HR, Gretch DR. Hepatitis C virus: current understanding and prospects for future therapies [ J ]. Mol Med Today, 1999, 5(9) :393 -399.
  • 5Bartenschlager R, Lohmann V. Replication of hepatitis C virus[J]. J Gen Virol, 2000, 81:1632 -1648.
  • 6Lohmann V, Hoffmann S, Herian U, et al. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture[J]. J Virol, 2003, 77(5):3007-3019.
  • 7Blight KJ, McKeating JA, Marcotrigiano J, et al. Efficient replication of hepatitis C virus genotype la RNAs in cell culture[J]. J Virol, 2003, 77(5) :3181 -3190.
  • 8Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication[ J]. J Virol, 2002, 76(24) : 13001 - 13014.
  • 9Murray EM, Grobler JA, Markel EJ,et al. Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells[J]. J Virol, 2003, 77(5) :2928 -2935.
  • 10Yang W, Qiu C, Biswas N, et al. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus[J]. J Biol Chem, 2008, 283 (13) :8643 - 8653.

二级参考文献16

  • 1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
  • 8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
  • 9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.
  • 10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20.

共引文献807

同被引文献9

  • 1张文军,李月琴,李泓剑,贾雪芳,张欣,周天鸿.Bridge Sequence对M1GS核酶体外切割活性的影响[J].广东药学院学报,2006,22(5):537-540. 被引量:5
  • 2Phong T, Kim K, Liu F. Developing RNase P ribozymes for gene-targeting and antiviral therapy [ J ]. Cell Microbiol,2004,6:499 - 508.
  • 3Zhang W J, Li HJ, Li YQ, et al. Effective inhibition of HCMV UL49 gene expression and viral replication by oligonucleotide external guide sequences and RNase P [ J ]. Virol J, 2010,7:381 -388.
  • 4Kim K, Liu FT. Inhibition of gene expression in human cells using RNase P-derived fibozymes and external guide sequences [J]. Biochim Biophys Acta, 2007, 1769:603 -612.
  • 5Yuan Y, Ahman S. Substrate recognition by human RNase P: Identification of small, model substrates for the enzyme [J]. EMBO J, 1995, 14:159-168.
  • 6Zhang WJ, Li ILl, Li Y Q, et al. Construction of an effective M1GS ribozyme targeting HCMV UL97 mRNA segment in vitro [ J ]. Acta Genetica Sinica, 2005, 32 : 1205 - 1212.
  • 7Walker SC, Engelke DR. Ribonuclease P: The evolution of an ancient RNA enzyme [J]. Crit Rev Biochem Mol Biol, 2006, 41 : 77 - 102.
  • 8Gomez J, Martell M, Quer J, et al. Hepatitis C viral quasispecies [J]. J Viral Hepat,1999,6:3 -16.
  • 9张玲霞,张战红,张敏.病毒性肝炎慢性化研究近况[J].基础医学与临床,1999,19(6):8-12. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部